{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T16:55:33Z","timestamp":1792083333756,"version":"4.4.0"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"DOI":"10.1186\/s12882-025-04114-2","type":"journal-article","created":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T14:18:55Z","timestamp":1745072335000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Renalase, dopamine, and norepinephrine as markers for the development of hypertension in CKD patients"],"prefix":"10.1186","volume":"26","author":[{"given":"Rafa\u0142","family":"Hery\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El\u017cbieta","family":"Cecerska-Hery\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Serwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrycja","family":"Stodolak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Goszka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Polikowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazimierz","family":"Ciechanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Wi\u015bniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,19]]},"reference":[{"issue":"10075","key":"4114_CR1","first-page":"1238","volume":"389","author":"AC Webster","year":"2017","unstructured":"Webster AC, Nagler EV, Morton RL, Masson P. Chronic Kidney Disease Lancet. 2017;389(10075):1238\u201352.","journal-title":"Chronic Kidney Disease Lancet"},{"issue":"8","key":"4114_CR2","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1001\/jama.2015.0602","volume":"313","author":"AS Levey","year":"2015","unstructured":"Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: A systematic review. JAMA. 2015;313(8):837\u201346.","journal-title":"JAMA"},{"key":"4114_CR3","first-page":"1443","volume-title":"Choroby Nerek dr\u00f3g Moczowych. Ostre Uszkodzenie Nerek i Przewlek\u0142a Choroba Nerek. Interna Szczeklika","year":"2022","unstructured":"Szczeklik A, red, editor. Choroby Nerek dr\u00f3g Moczowych. Ostre Uszkodzenie Nerek i Przewlek\u0142a Choroba Nerek. Interna Szczeklika. Krak\u00f3w: Medycyna Praktyczna; 2022. pp. 1443\u201361."},{"issue":"1","key":"4114_CR4","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2215\/CJN.07440618","volume":"14","author":"AR Chang","year":"2019","unstructured":"Chang AR, L\u00f3ser M, Malhotra R, Appel LJ. Blood pressure goals in patients with CKD: A review of evidence and guidelines. Clin J Am Soc Nephrol. 2019;14(1):161\u20139.","journal-title":"Clin J Am Soc Nephrol"},{"issue":"6","key":"4114_CR5","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1053\/j.ajkd.2019.12.005","volume":"75","author":"CP Walther","year":"2020","unstructured":"Walther CP, Nambi V, Hanania NA, Navaneethan SD. Diagnosis and management of pulmonary hypertension in patients with CKD. Am J Kidney Dis. 2020;75(6):935\u201345. https:\/\/doi.org\/10.1053\/j.ajkd.2019.12.005.","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"4114_CR6","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1053\/ajkd.2002.30542","volume":"39","author":"MP H\u00f6rl","year":"2002","unstructured":"H\u00f6rl MP, H\u00f6rl WH. Hemodialysis-associated hypertension: pathophysiology and therapy. Am J Kidney Dis. 2002;39(2):227\u201344.","journal-title":"Am J Kidney Dis"},{"key":"4114_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.5527\/wjn.v4.i2.196","volume":"4","author":"MR Choi","year":"2015","unstructured":"Choi MR, Kouyoumdzian NM, Rukavina Mikusic NL. I Wsp. Renal dopaminergic system: pathophysiological implications and clinical perspectives. World J Nephrol. 2015;4:196\u2013212.","journal-title":"World J Nephrol"},{"key":"4114_CR8","doi-asserted-by":"publisher","first-page":"110712","DOI":"10.1016\/j.biopha.2020.110712","volume":"131","author":"Y Li","year":"2020","unstructured":"Li Y, Wu W, Liu W, Zhou M. Roles and mechanisms of Renalase in cardiovascular disease: A promising therapeutic target. Biomed Pharmacother. 2020;131:110712.","journal-title":"Biomed Pharmacother"},{"issue":"8","key":"4114_CR9","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00109-006-0151-4","volume":"85","author":"Q Zhao","year":"2007","unstructured":"Zhao Q, Fan Z, He J. I Wsp. Renalase gene is a novel susceptibility gene for essential hypertension: a two-stage association study in Northern Han Chinese population. J Mol Med (Berl). 2007;85(8):877\u201385.","journal-title":"J Mol Med (Berl)"},{"issue":"11","key":"4114_CR10","doi-asserted-by":"publisher","first-page":"4162","DOI":"10.1093\/ndt\/gfr293","volume":"27","author":"A Stec","year":"2012","unstructured":"Stec A, Semczuk A, Furmaga J, Ksiazek A, Buraczynska M. Polymorphism of the Renalase gene in end-stage renal disease patients affected by hypertension. Nephrol Dial Transpl. 2012;27(11):4162\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"4114_CR11","first-page":"204","volume":"May","author":"M Nishihara","year":"2017","unstructured":"Nishihara M, Takesue K, Hirooka Y. Renal denervation enhances GABA-ergic input into the PVN leading to blood pressure Lowering in chronic kidney disease. Auton Neurosci. 2017;May:204\u201388.","journal-title":"Auton Neurosci"},{"key":"4114_CR12","doi-asserted-by":"crossref","unstructured":"Noh MR, Jang HS, Kim J, Padanilam BJ. Renal Sympathetic Nerve-Derived Signaling in Acute and Chronic Kidney Diseases. 2020 Int J Mol Sci. Feb 28;21(5):1647.","DOI":"10.3390\/ijms21051647"},{"key":"4114_CR13","doi-asserted-by":"crossref","unstructured":"Wisniewska M, Serwin N, Dziedziejko V, A. Renalase in Haemodialysis Patients with Chronic Kidney Disease. J Clin Med., Harris B, Zhang RC et al. M.Z. Intrarenal dopamine attenuates deoxycorticosterone acetate\/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension 2009;54:1077\u20131083.","DOI":"10.1161\/HYPERTENSIONAHA.109.137174"},{"key":"4114_CR14","doi-asserted-by":"crossref","unstructured":"Yao B, Harris R.C, Zhang M.Z. Intrarenal dopamine attenuates deoxycorticosterone acetate\/high salt-induced blood pressure elevation in part through activation of a medullary cyclooxygenase 2 pathway. Hypertension 2009;54:1077\u20131083.","DOI":"10.1161\/HYPERTENSIONAHA.109.137174"},{"key":"4114_CR15","first-page":"117","volume":"132","author":"GV Desir","year":"2022","unstructured":"Desir GV. Renalase: discovery, biology, and therapeutic applications. Trans Am Clin Climatol Assoc. 2022;132:117\u201325.","journal-title":"Trans Am Clin Climatol Assoc"},{"key":"4114_CR16","doi-asserted-by":"crossref","unstructured":"Gok Oguz E, Akoglu H, Ulusal Okyay G et al. Increased serum Renalase in peritoneal dialysis patients: is it related to cardiovascular disease risk? Nefrologia. 2017 Mar-Apr;37(2):189\u201394.","DOI":"10.1016\/j.nefro.2016.11.013"},{"issue":"12","key":"4114_CR17","doi-asserted-by":"publisher","first-page":"6282","DOI":"10.3390\/ijerph18126282","volume":"18","author":"M Wi\u015bniewska","year":"2021","unstructured":"Wi\u015bniewska M, Serwin N, Dziedziejko V, et al. The effect of bilateral nephrectomy on Renalase and catecholamines in Hemodialysis patients. Int J Environ Res Public Health. 2021;18(12):6282.","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"4114_CR18","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1042\/CS20190995","volume":"134","author":"J Yin","year":"2020","unstructured":"Yin J, Liu X, Zhao T, Liang R, Wu R, Zhang F, Kong Y, Liu L, Xing T, Wang N, Zhao Q, Wang F. A protective role of Renalase in diabetic nephropathy. Clin Sci (Lond). 2020;134(1):75\u201385.","journal-title":"Clin Sci (Lond)"},{"issue":"1","key":"4114_CR19","doi-asserted-by":"publisher","first-page":"20220940","DOI":"10.1515\/biol-2022-0940","volume":"19","author":"Y Wu","year":"2024","unstructured":"Wu Y, Feng Y, Yu Y, Bai Y, Diao Z, Liu W. Renalase protects against podocyte injury by inhibiting oxidative stress and apoptosis in diabetic nephropathy. Open Life Sci. 2024;19(1):20220940.","journal-title":"Open Life Sci"},{"issue":"1","key":"4114_CR20","first-page":"39","volume":"43","author":"MA Aydin","year":"2024","unstructured":"Aydin MA, Aydogdu N, Tastekin E, Firat N, Yalcinkaya Yavuz O. Investigation of the relationship of Nesfatin-1, Adropin levels and Claudin-2, Renalase immunoreactivity with kidney function in an experimental hypertension model. P R Health Sci J. 2024;43(1):39\u201345.","journal-title":"P R Health Sci J"},{"key":"4114_CR21","doi-asserted-by":"publisher","first-page":"40","DOI":"10.20452\/pamw.1132","volume":"122","author":"E Zbroch","year":"2012","unstructured":"Zbroch E, Malyszko J, Koc-Zorawska E, Mysliwiec M. Renalase, kidney function, and markers of endothelial dysfunction in renal transplant recipients. Pol Arch Med Wewn. 2012;122:40\u20134.","journal-title":"Pol Arch Med Wewn"},{"key":"4114_CR22","doi-asserted-by":"crossref","unstructured":"Zbroch E, Malyszko J, Malyszko J et al. Renalase in peritoneal dialysis patients is not related to blood pressure, but to dialysis vintage. Perit Dial Int. 2012 May-Jun;32(3):348\u201351.","DOI":"10.3747\/pdi.2011.00118"},{"issue":"6","key":"4114_CR23","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1159\/000338178","volume":"35","author":"E Zbroch","year":"2012","unstructured":"Zbroch E, Malyszko J, Malyszko JS, Koc-Zorawska E, Mysliwiec M. Renalase, a novel enzyme involved in blood pressure regulation, is related to kidney function but not to blood pressure in Hemodialysis patients. Kidney Blood Press Res. 2012;35(6):395\u20139.","journal-title":"Kidney Blood Press Res"},{"issue":"5","key":"4114_CR24","first-page":"863","volume":"30","author":"B He","year":"2014","unstructured":"He B, Hao J, Sheng W, Xiang Y, Zhang J, Zhu H, et al. Correlation between plasma Renalase level and coronary artery disease. Pak J Med Sci. 2014;30(5):863\u2013967.","journal-title":"Pak J Med Sci"},{"issue":"1","key":"4114_CR25","doi-asserted-by":"publisher","first-page":"134","DOI":"10.2174\/1570161113666141217141805","volume":"13","author":"J Malyszko","year":"2015","unstructured":"Malyszko J, Koc-Zorawska E, Zorawski M, Kozminski P, Zbroch E, Rysz J, Banach M, Malyszko JS. Renalase is removed by kidneys and during dialysis - excess related to CKD complications? Curr Vasc Pharmacol. 2015;13(1):134\u201340.","journal-title":"Curr Vasc Pharmacol"},{"issue":"3","key":"4114_CR26","first-page":"210","volume":"11","author":"A Cerqueira","year":"2021","unstructured":"Cerqueira A, Quelhas-Santos J, Ferreira I, et al. Circulating renalase as predictor of renal and cardiovascular outcomes in Pre-Dialysis CKD patients: A 5-Year prospective cohort study. Life (Basel). 2021;11(3):210.","journal-title":"Life (Basel)"},{"issue":"22","key":"4114_CR27","doi-asserted-by":"publisher","first-page":"3241","DOI":"10.2169\/internalmedicine.0994-18","volume":"57","author":"T Matsuyama","year":"2018","unstructured":"Matsuyama T, Ohashi N, Ishigaki S, et al. The relationship between the intrarenal dopamine system and intrarenal Renin-angiotensin system depending on the renal function. Intern Med. 2018;57(22):3241\u20137.","journal-title":"Intern Med"},{"key":"4114_CR28","first-page":"37","volume":"15","author":"W Januszewicz","year":"2011","unstructured":"Januszewicz W, P\u0119czkowska M, Michel-Rowicka K. Dopamina \u2014 aspekty Patofizjologiczne i kliniczne. Arterial Hypertens. 2011;15:37\u201341.","journal-title":"Arterial Hypertens"},{"issue":"1","key":"4114_CR29","doi-asserted-by":"publisher","first-page":"6","DOI":"10.23876\/j.krcp.18.0143","volume":"38","author":"HS Jang","year":"2019","unstructured":"Jang HS, Kim J, Padanilam BJ. Renal sympathetic nerve activation via \u03b12-adrenergic receptors in chronic kidney disease progression. Kidney Res Clin Pract. 2019;38(1):6\u201314.","journal-title":"Kidney Res Clin Pract"},{"key":"4114_CR30","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1038\/nrneph.2017.132","volume":"13","author":"MD Okusa","year":"2017","unstructured":"Okusa MD, Rosin DL, Tracey KJ. Targeting neural reflex circuits in immunity to treat kidney disease. Nat Rev Nephrol. 2017;13:669\u201380.","journal-title":"Nat Rev Nephrol"},{"key":"4114_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/HJH.0b013e328332bc87","volume":"28","author":"Y Chen","year":"2010","unstructured":"Chen Y, Wen G, Rao F, et al. Human dopamine beta-hydroxylase (DBH) regulatory polymorphism that influences enzymatic activity, autonomic function, and blood pressure. J Hypertens. 2010;28:76\u201386.","journal-title":"J Hypertens"},{"key":"4114_CR32","doi-asserted-by":"crossref","unstructured":"Remuzzi G, Perico N, Macia M, Ruggenenti P. The role of renin-angiotensin-aldosterone system in the progression of chronic kidney disease. Kidney Int Suppl. 2005;(99):S57\u201365.","DOI":"10.1111\/j.1523-1755.2005.09911.x"},{"key":"4114_CR33","doi-asserted-by":"publisher","first-page":"566871","DOI":"10.3389\/fphys.2020.566871","volume":"11","author":"L Hering","year":"2020","unstructured":"Hering L, Rahman M, Potthoff SA, et al. Role of \u03b12-Adrenoceptors in hypertension: focus on renal sympathetic neurotransmitter release, inflammation, and sodium homeostasis. Front Physiol. 2020;11:566871.","journal-title":"Front Physiol"},{"key":"4114_CR34","doi-asserted-by":"crossref","unstructured":"Zoccali C, Mallamaci F, Parlongo S. I Wsp. Plasma norepinephrine predicts survival and incident cardiovascular events in patients with End-Stage renal disease circulation. Circulation. 2002;7:2230.","DOI":"10.1161\/hc1102.105261"},{"issue":"6","key":"4114_CR35","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1097\/HJH.0b013e3280f9df85","volume":"25","author":"O Zilch","year":"2007","unstructured":"Zilch O, Vos PF, Oey I, et al. Sympathetic hyperactivity in haemodialysis patients is reduced by short daily haemodialysis. J Hypertens. 2007;25(6):1285\u20139.","journal-title":"J Hypertens"},{"issue":"2","key":"4114_CR36","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1007\/s11906-021-01129-6","volume":"23","author":"F Quarti-Trevano","year":"2021","unstructured":"Quarti-Trevano F, Seravalle G, Dell\u2019Oro R, et al. Autonomic cardiovascular alterations in chronic kidney disease: effects of dialysis, kidney transplantation, and renal denervation. Curr Hypertens Rep. 2021;23(2):10.","journal-title":"Curr Hypertens Rep"},{"key":"4114_CR37","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/0895-7061(95)00155-I","volume":"8","author":"K Freeman","year":"1995","unstructured":"Freeman K, Farrow S, Schmaier A, et al. Genetic polymorphism of the alpha 2-adrenergic receptor is associated with increased platelet aggregation, baroreceptor sensitivity, and salt excretion in normotensive humans. Am J Hypertens. 1995;8:863\u20139. https:\/\/doi.org\/10.1016\/0895-7061(95)00155-I.","journal-title":"Am J Hypertens"},{"key":"4114_CR38","doi-asserted-by":"publisher","unstructured":"GBD 2016 Risk Factors Collaborator. Global, regional, and National comparative risk assessment of 84 behaviournvironmental and occupational, and metabolic risks or clusters of risks, 1990\u20132016: a systematic analysis for the global burden of disease study 2016. Lancet 390, 1345\u2013422. https:\/\/doi.org\/10.1016\/S0140-6736(17)32366-8","DOI":"10.1016\/S0140-6736(17)32366-8"},{"issue":"4","key":"4114_CR39","doi-asserted-by":"publisher","first-page":"858","DOI":"10.3904\/kjim.2017.058","volume":"34","author":"SH Baek","year":"2019","unstructured":"Baek SH, Cha RH, Kang SW, et al. Circulating Renalase predicts all-cause mortality and renal outcomes in patients with advanced chronic kidney disease. Korean J Intern Med. 2019;34(4):858\u201366.","journal-title":"Korean J Intern Med"},{"issue":"10","key":"4114_CR40","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.3390\/biom11101514","volume":"11","author":"W Knop","year":"2021","unstructured":"Knop W, Serwin NM, Cecerska-Hery\u0107 E, et al. Elevated levels of Renalase, the \u03b2-NAD(P)H isomerase, can be used as risk factors of major adverse cardiovascular events and All-Cause death in patients with chronic kidney disease. Biomolecules. 2021;11(10):1514.","journal-title":"Biomolecules"},{"issue":"7","key":"4114_CR41","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1172\/JCI57324","volume":"121","author":"MZ Zhang","year":"2011","unstructured":"Zhang MZ, Yao B, Wang S, et al. Intrarenal dopamine deficiency leads to hypertension and decreased longevity in mice. J Clin Invest. 2011;121(7):2845\u201354.","journal-title":"J Clin Invest"},{"issue":"Suppl 1","key":"4114_CR42","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1291\/hypres.18.SupplementI_S87","volume":"18","author":"M Yoshimura","year":"1995","unstructured":"Yoshimura M, Komori T, Nishimura M, et al. Diagnostic significance of dopamine Estimation using plasma and urine in patients with adrenal and renal insufficiency, renal transplantation and hypertension. Hypertens Res. 1995;18(Suppl 1):S87\u201392.","journal-title":"Hypertens Res"},{"issue":"1","key":"4114_CR43","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1007\/s10157-014-0951-8","volume":"19","author":"F Wang","year":"2015","unstructured":"Wang F, Li J, Xing T, Xie Y, Wang N. Serum Renalase is related to catecholamine levels and renal function. Clin Exp Nephrol. 2015;19(1):92\u20138.","journal-title":"Clin Exp Nephrol"},{"issue":"3","key":"4114_CR44","doi-asserted-by":"publisher","first-page":"166","DOI":"10.2174\/1573402111666150108101709","volume":"10","author":"J Quelhas-Santos","year":"2014","unstructured":"Quelhas-Santos J, Pestana M. Plasma Renalase in chronic kidney disease: differences and similarities between humans and rats. Curr Hypertens Rev. 2014;10(3):166\u201370.","journal-title":"Curr Hypertens Rev"},{"key":"4114_CR45","doi-asserted-by":"publisher","unstructured":"Desir GV, Wang L, Peixoto AJ. Human Renalase: a review of its biology, function, and implications for hypertension. J Am Soc Hypertens. 2012 Nov-Dec;6(6):417\u201326. https:\/\/doi.org\/10.1016\/j.jash.2012.09.002.","DOI":"10.1016\/j.jash.2012.09.002"},{"issue":"5","key":"4114_CR46","doi-asserted-by":"publisher","first-page":"673","DOI":"10.3109\/0886022X.2013.778754","volume":"35","author":"E Zbroch","year":"2013","unstructured":"Zbroch E, Koc-Zorawska E, Malyszko J, et al. Circulating levels of Renalase, norepinephrine, and dopamine in dialysis patients. Ren Fail. 2013;35(5):673\u20139.","journal-title":"Ren Fail"},{"issue":"8","key":"4114_CR47","doi-asserted-by":"publisher","first-page":"1180","DOI":"10.1080\/0886022X.2016.1208516","volume":"38","author":"EG Oguz","year":"2016","unstructured":"Oguz EG, Gursoy GK, Yayar O, et al. Increased serum Renalase in Hemodialysis patients: is it related to left ventricular hypertrophy? Ren Fail. 2016;38(8):1180\u20136.","journal-title":"Ren Fail"},{"key":"4114_CR48","doi-asserted-by":"publisher","unstructured":"Desir GV, Tang L, Wang P, Li G, Sampaio-Maia B, Quelhas-Santos J, Pestana M, Velazquez H. Renalase lowers ambulatory blood pressure by metabolizing circulating adrenaline. J Am Heart Assoc. 2012;1(4):e002634. https:\/\/doi.org\/10.1161\/JAHA.112.002634. Epub 2012 Aug 24.","DOI":"10.1161\/JAHA.112.002634"}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04114-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-025-04114-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-025-04114-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T14:19:01Z","timestamp":1745072341000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-025-04114-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,19]]},"references-count":48,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4114"],"URL":"https:\/\/doi.org\/10.1186\/s12882-025-04114-2","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,19]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patients included in the study gave informed consent to participate. The study was approved by the Bioethics Committee at the Pomeranian Medical University in Szczecin (no KB-0012\/36\/11).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for the publication of this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"200"}}